登录
免费注册
首页
论文
论文详情
赞
收藏
引用
分享
科研之友
微信
新浪微博
Facebook
分享链接
Alemtuzumab Has Durable Efficacy on MRI Outcomes and Brain Atrophy Over 5 Years with Most Patients Free From Treatment for 4 Years: CARE-MS II Extension Study
作者:King J; Traboulsee A; Compston D A S; Hartung H P; Havrdova E; Selmaj K W; Margolin D H; Thangavelu K; Barkhof F
来源:
8th Congress of the Pan-Asian-Committee-for-Research-and-Treatment-of-Multiple-Sclerosis (PACTRIMS)
, 2015-11-19 to 2015-11-21.
相似论文
引用论文
参考文献